ProfileGDS5822 / ILMN_2686178
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 5% 31% 22% 5% 19% 58% 10% 46% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 17.85
GSM1276600PDAC Late Ablation Control 217.631
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 111.922
GSM1276603PDAC Late Ablation 26.15
GSM1276604PDAC Late Ablation 311.819
GSM1303940PDAC Late Ablation_anti-CTLA4 126.858
GSM1303941PDAC Late Ablation_anti-CTLA4 26.810
GSM1303942PDAC Late Ablation_anti-CTLA4 322.646